跳至主要内容
临床试验/NCT01190163
NCT01190163终止4 期

Phase IV, Multicenter, Open Label, Randomized Trial to Compare the Effectiveness and Safety of the Dinoprostone Vaginal Pessary vs. Oxytocin for Women Requiring Cervical Ripening Prior to Induction of Labor

Ferring Pharmaceuticals4 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
170
试验地点
4
主要终点
Vaginal birth delivery within 24 hours and C-section rate

研究概览

简要总结

This is a comparative trial between oxytocin alone and dinoprostone for cervical ripening in unfavorable cervix pregnant women with 38 or more weeks of gestational age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton pregnancy
  • Gestational age ≥ 38 weeks
  • Fetal cephalic presentation
  • Bishop score < 6

排除标准

  • No uterine scar (no previous delivery by caesarean section)
  • No more than 3 previous vaginal births
  • No condition that disallows use of prostaglandins for induction of labor
  • Premature rupture of the membranes
  • Oligohydramnios

研究组 & 干预措施

A

Experimental

干预措施: Dinoprostone (Drug)

B

Active Comparator

干预措施: Oxytocin (Drug)

结局指标

主要结局

Vaginal birth delivery within 24 hours and C-section rate

时间窗: 24 hours

次要结局

  • Treatment failure rate(24 hours)
  • Uterine hyperstimulation and/or fetal distress(24 hours)
  • Use of additional oxytocin(24 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Open Label Comparative Trial of Dinoprostone Plus or... | 临床试验